In assessing HD exposure, which lab study could be relevant?

A baseline complete blood count is relevant in assessing hazardous drug (HD) exposure because it can help in monitoring the hematological effects of exposure to these substances. Hazardous drugs can potentially cause toxicity to the bone marrow, leading to changes in blood cell counts. A complete blood count allows healthcare providers to evaluate key components such as red blood cells, white blood cells, and platelets, which can be affected by exposure to chemotherapeutic agents and other hazardous drugs.

Evaluating a baseline complete blood count provides valuable information regarding the patient's overall health and can assist in early detection of adverse effects due to HD exposure, enabling appropriate intervention if abnormalities are noted. Regular monitoring through such blood tests is a vital aspect of ensuring patient safety and health while working with or around hazardous drugs.

While cholesterol levels, blood pressure, and urine drug screens have their own clinical significance, they do not specifically address the potential hematological toxicity associated with hazardous drug exposure in the same manner that a complete blood count does.